E. P. Krenning - Concepedia

Author

E. P. Krenning

Also Known As

Amy Christensen, E Krenning, E P Krenning, E. KRENNING, E. Krenning, E. P. KRENNING, E. P. Krenning, E.P Krenning, E.P. KRENNING, E.P. Krenning

214

Publications

16.7K

Citations

H-Index

144

Concepts

All Affiliations

Erasmus University Rotterdam Rotterdam University of Applied Sciences Erasmus MC University of Bern

About

E. P. Krenning is an author at Erasmus University Rotterdam specializing in medicine, radiology, and nuclear medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	71	8.1K
2	Health Sciences	18	20	2.7K
3	Engineering	15	15	2.4K
4	Public Health	9	9	314
5	Natural Sciences	3	3	88

E. P. Krenning

114

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Marianne Pavel, Kjell Öberg, M. Falconi, Annals of Oncology Endocrine OncologyGastroenteropancreatic Neuroendocrine NeoplasmsNeuroendocrine DisorderGastroenterologyPathology	2020	1.1K
ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site Marianne Pavel, Dermot O’Toole, Frederico Costa, Neuroendocrinology GastroenterologyPathologyDiagnosisGuidelines PaperSurgery	2016	1K
LOCALISATION OF ENDOCRINE-RELATED TUMOURS WITH RADIOIODINATED ANALOGUE OF SOMATOSTATIN E. P. Krenning, Wout A. P. Breeman, P.P.M. Kooij, The Lancet MedicineNeuroendocrine DisorderPathologyEndocrinologyOncology	1989	620
Somatostatin-Receptor Imaging in the Localization of Endocrine Tumors S.W.J. Lamberts, W. Halsey Barker, J.C. Reubi, New England Journal of Medicine	1990	532
ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and Ileum Bruno Niederle, Ulrich F. Pape, Frederico Costa, Neuroendocrinology	2016	469
Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. E. P. Krenning, WH Bakker, P P Kooij, PubMed EngineeringPathologyPositron Emission TomographyTheranosticsNormal Pituitary	1992	422
Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA0,Tyr3]octreotate Dik J. Kwekkeboom, Willem H. Bakker, Boen L.R. Kam, European Journal of Nuclear Medicine and Molecular Imaging Surgical OncologyPancreatic CancerMedicineGastroenterologyPathology	2003	418
Peptide receptor imaging and therapy. D. J. Kwekkeboom, E. P. Krenning, Marion de Jong PubMed EngineeringPathologyTumor VisualizationPeptide SciencePeptide Therapeutics	2000	330
[111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation Willem H. Bakker, Rainer Albert, Christian Bruns, Life Sciences EngineeringOncologic ImagingPotential RadiopharmaceuticalTheranosticsMolecular Imaging	1991	327
Radiotherapy with a Radiolabeled Somatostatin Analogue, [<sup>111</sup>In‐DTPA‐<scp>d</scp>‐Phe<sup>1</sup>]‐Octreotide E. P. Krenning, P.P.M. Kooij, Willem H. Bakker, Annals of the New York Academy of Sciences Radiation MedicineRadiation TherapyMedicineRadionuclide TherapyRadiopharmaceutical Therapy	1994	307

Page 1